Literature DB >> 8096969

Clinical management of pulmonary disease in cystic fibrosis.

S B Fiel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096969     DOI: 10.1016/0140-6736(93)92423-q

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro.

Authors:  N G Barclay; J C Spurrell; T F Bruno; D G Storey; D E Woods; C H Mody
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis.

Authors:  E Caballero; M E Drobnic; M T Pérez; J M Manresa; A Ferrer; R Orriols
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

3.  Altered cytokine production by cystic fibrosis tracheal gland serous cells.

Authors:  W Kammouni; C Figarella; S Marchand; M Merten
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

Review 4.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

5.  Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections.

Authors:  S Payen; R Serreau; A Munck; Y Aujard; Y Aigrain; F Bressolle; E Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 6.  Cystic fibrosis.

Authors:  M R Bye; J M Ewig; L M Quittell
Journal:  Lung       Date:  1994       Impact factor: 2.584

7.  Stability of aztreonam in a portable pump reservoir used for home intravenous antibiotic treatment (HIVAT).

Authors:  A A Vinks; D J Touw; R C van Rossen; H G Heijerman; W Bakker
Journal:  Pharm World Sci       Date:  1996-04

Review 8.  Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?

Authors:  V Witko-Sarsat; I Sermet-Gaudelus; G Lenoir; B Descamps-Latscha
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.